VASCLIR

Serial Number 77397503
606

Registration Progress

Application Filed
Feb 14, 2008
Under Examination
May 12, 2009
Approved for Publication
Jan 28, 2009
Published for Opposition
Feb 17, 2009
Registered

Trademark Image

VASCLIR

Basic Information

Serial Number
77397503
Filing Date
February 14, 2008
Published for Opposition
February 17, 2009
Abandonment Date
December 12, 2011
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 12, 2011
Classes
001 005 042 044

Rights Holder

Vermillion, Inc.

03
Address
12117 Bee Caves Road
Austin, TX 78738

Ownership History

Vermillion, Inc.

Original Applicant
03
Fremont, CA

Vermillion, Inc.

Owner at Publication
03
Austin, TX

Legal Representation

Attorney
Peter F. Corless

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

41 events
Date Code Type Description Documents
Dec 12, 2011 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 12, 2011 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Apr 6, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 5, 2011 EX4G S SOU EXTENSION 4 GRANTED Loading...
Mar 30, 2011 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 30, 2011 EXT4 S SOU EXTENSION 4 FILED Loading...
Oct 8, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 7, 2010 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 4, 2010 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 4, 2010 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 12, 2010 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Aug 12, 2010 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 14, 2010 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
May 13, 2010 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 11, 2010 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 11, 2010 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 11, 2010 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 11, 2010 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 8, 2010 UNDC O UNDELIVERABLE MAIL - COURTESY COPY MAILED Loading...
Dec 21, 2009 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Dec 21, 2009 PETG O PETITION TO REVIVE-GRANTED Loading...
Dec 21, 2009 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
Dec 14, 2009 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 14, 2009 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Nov 12, 2009 EXT1 S SOU EXTENSION 1 FILED Loading...
May 12, 2009 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 1, 2009 WOAR I TEAS WITHDRAWAL OF ATTORNEY RECEIVED Loading...
May 1, 2009 WOAG I WITHDRAWAL OF ATTORNEY GRANTED Loading...
Feb 17, 2009 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 28, 2009 NPUB O NOTICE OF PUBLICATION Loading...
Jan 13, 2009 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jan 6, 2009 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 5, 2008 ALIE A ASSIGNED TO LIE Loading...
Dec 5, 2008 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 5, 2008 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 21, 2008 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 29, 2008 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 29, 2008 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 29, 2008 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 27, 2008 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 20, 2008 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Reagents for scientific or medical research use
First Use Anywhere: 0
First Use in Commerce: 0
Class 005
Reagents, diagnostic preparations for medical purposes; diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Providing medical and scientific research in the field of pharmaceutical and clinical trials; medical and scientific research services in the field of cancer treatment and diagnosis; providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; product development services for others in the biomedical, genomics, pharmacogenomics, diagnostic, clinical trial design and biotechnology fields
First Use Anywhere: 0
First Use in Commerce: 0
Class 044
Providing medical information
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Translation
The mark "VASCLIR" has no meaning in a foreign language.

Classification

International Classes
001 005 042 044